Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S11 from Defining the Antitumor Mechanism of Action of a Clinical-stage Compound as a Selective Degrader of the Nuclear Pore Complex
  1. Home
  2. Publications
  3. Figure S11 from Defining the Antitumor Mechanism of Action of a Clinical-stage Compound as a Selective Degrader of the Nuclear Pore Complex

Figure S11 from Defining the Antitumor Mechanism of Action of a Clinical-stage Compound as a Selective Degrader of the Nuclear Pore Complex

Authors:
  • LYLinjie Yuan
    Linjie Yuan
  • WJWenzhi Ji
    Wenzhi Ji
  • BDBrendan G. Dwyer
    Brendan G. Dwyer
  • JLJoey Lu
    Joey Lu
  • JBJing Bian
    Jing Bian
  • GCGianna M. Colombo
    Gianna M. Colombo
  • MMMichael J. Martinez
    Michael J. Martinez
  • DFDaniel Fernandez
    Daniel Fernandez
  • NPNick A. Phillips
    Nick A. Phillips
  • MTMichelle T. Tang
    Michelle T. Tang
  • CZChristine Wenjie Zhou
    Christine Wenjie Zhou
  • NCNirk E. Quispe Calla
    Nirk E. Quispe Calla

Open Access
Publisher website
Google Scholar
  • 2 December 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2159-8290.30761431
Abstract
Depicts live-cell imaging, lethal fraction analyses, and protein interaction/immunoblot assays demonstrating TRIM21-dependent PRLX-induced nucleoporin destabilization and rapid cancer cell death.
Keywords
  • DRUG MECHANISMS
  • CELLULAR RESPONSES TO ANTICANCER DRUGS
  • DRUG TARGETS
  • GASTROINTESTINAL CANCERS
  • PANCREATIC CANCER
  • PHARMACOLOGY
  • MOLECULAR PHARMACOLOGY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.